Company intelligence / Profile preview

Botanicure

Nazareth, Israel

Ownership: Private
Development stage: Other

Overview

Botanicure is a B2B longevity science company that develops and provides scientifically-validated natural compounds and formulations for human and pet health. The company focuses on targeting the root causes of aging through proprietary strategies such as ClearSenescent (senolytics), GLP-1 Activation Technology, and ActivatePathways. Its product portfolio includes Botagovy, a plant-based GLP-1 activator for weight management, and Senolytine, a senolytic compound designed to eliminate senescent cells. Botanicure partners with dietary supplement, functional food, and pharmaceutical companies to integrate its bioactive ingredients into various delivery formats.

Therapeutic areas: EndocrinologyOtherMetabolic DisordersImmunology
Modalities: Botanical extractPeptidesSmall molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on Botanicure.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Botanicure.

Explore the full profile